nodes	percent_of_prediction	percent_of_DWPC	metapath
Piperacillin—Rigors—Capecitabine—colon cancer	0.00743	0.00743	CcSEcCtD
Piperacillin—Deep vein thrombosis—Methotrexate—colon cancer	0.00743	0.00743	CcSEcCtD
Piperacillin—Eruption—Methotrexate—colon cancer	0.00735	0.00735	CcSEcCtD
Piperacillin—Thrombophlebitis—Fluorouracil—colon cancer	0.00728	0.00728	CcSEcCtD
Piperacillin—Anaphylactoid reaction—Irinotecan—colon cancer	0.0068	0.0068	CcSEcCtD
Piperacillin—Hyperbilirubinaemia—Capecitabine—colon cancer	0.00667	0.00667	CcSEcCtD
Piperacillin—Liver disorder—Methotrexate—colon cancer	0.00663	0.00663	CcSEcCtD
Piperacillin—Dermatitis bullous—Fluorouracil—colon cancer	0.0066	0.0066	CcSEcCtD
Piperacillin—Blood bilirubin increased—Capecitabine—colon cancer	0.00642	0.00642	CcSEcCtD
Piperacillin—Blood creatinine increased—Irinotecan—colon cancer	0.00617	0.00617	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Vincristine—colon cancer	0.00609	0.00609	CcSEcCtD
Piperacillin—Injection site reaction—Capecitabine—colon cancer	0.00603	0.00603	CcSEcCtD
Piperacillin—Hypokalaemia—Irinotecan—colon cancer	0.00599	0.00599	CcSEcCtD
Piperacillin—Muscular weakness—Vincristine—colon cancer	0.00596	0.00596	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.00593	0.00593	CcSEcCtD
Piperacillin—Candida infection—Capecitabine—colon cancer	0.00579	0.00579	CcSEcCtD
Piperacillin—Muscular weakness—Fluorouracil—colon cancer	0.00556	0.00556	CcSEcCtD
Piperacillin—Pancytopenia—Vincristine—colon cancer	0.00555	0.00555	CcSEcCtD
Piperacillin—Sweating increased—Irinotecan—colon cancer	0.00554	0.00554	CcSEcCtD
Piperacillin—Ecchymosis—Capecitabine—colon cancer	0.00549	0.00549	CcSEcCtD
Piperacillin—Neutropenia—Vincristine—colon cancer	0.00546	0.00546	CcSEcCtD
Piperacillin—Eosinophilia—Fluorouracil—colon cancer	0.0054	0.0054	CcSEcCtD
Piperacillin—Neutropenia—Irinotecan—colon cancer	0.00532	0.00532	CcSEcCtD
Piperacillin—Pancytopenia—Fluorouracil—colon cancer	0.00518	0.00518	CcSEcCtD
Piperacillin—Phlebitis—Capecitabine—colon cancer	0.00511	0.00511	CcSEcCtD
Piperacillin—Thrombophlebitis—Capecitabine—colon cancer	0.00509	0.00509	CcSEcCtD
Piperacillin—Stomatitis—Vincristine—colon cancer	0.00508	0.00508	CcSEcCtD
Piperacillin—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.00507	0.00507	CcSEcCtD
Piperacillin—Bone disorder—Methotrexate—colon cancer	0.005	0.005	CcSEcCtD
Piperacillin—Renal failure—Irinotecan—colon cancer	0.00499	0.00499	CcSEcCtD
Piperacillin—Hyperbilirubinaemia—Methotrexate—colon cancer	0.00497	0.00497	CcSEcCtD
Piperacillin—Stomatitis—Irinotecan—colon cancer	0.00495	0.00495	CcSEcCtD
Piperacillin—Jaundice—Irinotecan—colon cancer	0.00495	0.00495	CcSEcCtD
Piperacillin—Vascular purpura—Capecitabine—colon cancer	0.00493	0.00493	CcSEcCtD
Piperacillin—Haemolytic anaemia—Capecitabine—colon cancer	0.00488	0.00488	CcSEcCtD
Piperacillin—Infestation NOS—Fluorouracil—colon cancer	0.00486	0.00486	CcSEcCtD
Piperacillin—Infestation—Fluorouracil—colon cancer	0.00486	0.00486	CcSEcCtD
Piperacillin—Stomatitis—Fluorouracil—colon cancer	0.00474	0.00474	CcSEcCtD
Piperacillin—Hallucination—Vincristine—colon cancer	0.00465	0.00465	CcSEcCtD
Piperacillin—Urinary tract disorder—Vincristine—colon cancer	0.00462	0.00462	CcSEcCtD
Piperacillin—Dermatitis bullous—Capecitabine—colon cancer	0.00461	0.00461	CcSEcCtD
Piperacillin—Urethral disorder—Vincristine—colon cancer	0.00458	0.00458	CcSEcCtD
Piperacillin—Epistaxis—Fluorouracil—colon cancer	0.00458	0.00458	CcSEcCtD
Piperacillin—Haemoglobin—Irinotecan—colon cancer	0.00458	0.00458	CcSEcCtD
Piperacillin—Purpura—Capecitabine—colon cancer	0.00457	0.00457	CcSEcCtD
Piperacillin—Haemorrhage—Irinotecan—colon cancer	0.00455	0.00455	CcSEcCtD
Piperacillin—Agranulocytosis—Fluorouracil—colon cancer	0.00453	0.00453	CcSEcCtD
Piperacillin—Haemoglobin—Fluorouracil—colon cancer	0.00438	0.00438	CcSEcCtD
Piperacillin—Haemorrhage—Fluorouracil—colon cancer	0.00436	0.00436	CcSEcCtD
Piperacillin—Angiopathy—Vincristine—colon cancer	0.00424	0.00424	CcSEcCtD
Piperacillin—Flushing—Irinotecan—colon cancer	0.00423	0.00423	CcSEcCtD
Piperacillin—Angiopathy—Irinotecan—colon cancer	0.00413	0.00413	CcSEcCtD
Piperacillin—Blood creatinine increased—Capecitabine—colon cancer	0.00413	0.00413	CcSEcCtD
Piperacillin—Immune system disorder—Irinotecan—colon cancer	0.00411	0.00411	CcSEcCtD
Piperacillin—Chills—Irinotecan—colon cancer	0.00409	0.00409	CcSEcCtD
Piperacillin—Ecchymosis—Methotrexate—colon cancer	0.00409	0.00409	CcSEcCtD
Piperacillin—Hypokalaemia—Capecitabine—colon cancer	0.00401	0.00401	CcSEcCtD
Piperacillin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00397	0.00397	CcSEcCtD
Piperacillin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00397	0.00397	CcSEcCtD
Piperacillin—Muscular weakness—Capecitabine—colon cancer	0.00389	0.00389	CcSEcCtD
Piperacillin—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00389	0.00389	CcSEcCtD
Piperacillin—Erythema—Fluorouracil—colon cancer	0.0038	0.0038	CcSEcCtD
Piperacillin—Thrombophlebitis—Methotrexate—colon cancer	0.00379	0.00379	CcSEcCtD
Piperacillin—Anaemia—Vincristine—colon cancer	0.00376	0.00376	CcSEcCtD
Piperacillin—Sweating increased—Capecitabine—colon cancer	0.00371	0.00371	CcSEcCtD
Piperacillin—Anaemia—Irinotecan—colon cancer	0.00366	0.00366	CcSEcCtD
Piperacillin—Leukopenia—Vincristine—colon cancer	0.00364	0.00364	CcSEcCtD
Piperacillin—Pancytopenia—Capecitabine—colon cancer	0.00362	0.00362	CcSEcCtD
Piperacillin—Neutropenia—Capecitabine—colon cancer	0.00356	0.00356	CcSEcCtD
Piperacillin—Leukopenia—Irinotecan—colon cancer	0.00355	0.00355	CcSEcCtD
Piperacillin—Convulsion—Vincristine—colon cancer	0.00353	0.00353	CcSEcCtD
Piperacillin—Anaemia—Fluorouracil—colon cancer	0.00351	0.00351	CcSEcCtD
Piperacillin—Myalgia—Vincristine—colon cancer	0.00347	0.00347	CcSEcCtD
Piperacillin—Leukopenia—Fluorouracil—colon cancer	0.0034	0.0034	CcSEcCtD
Piperacillin—Infestation—Capecitabine—colon cancer	0.0034	0.0034	CcSEcCtD
Piperacillin—Infestation NOS—Capecitabine—colon cancer	0.0034	0.0034	CcSEcCtD
Piperacillin—Anaphylactoid reaction—Methotrexate—colon cancer	0.00339	0.00339	CcSEcCtD
Piperacillin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00337	0.00337	CcSEcCtD
Piperacillin—Renal failure—Capecitabine—colon cancer	0.00334	0.00334	CcSEcCtD
Piperacillin—Anaphylactic shock—Vincristine—colon cancer	0.00332	0.00332	CcSEcCtD
Piperacillin—Oedema—Vincristine—colon cancer	0.00332	0.00332	CcSEcCtD
Piperacillin—Stomatitis—Capecitabine—colon cancer	0.00331	0.00331	CcSEcCtD
Piperacillin—Jaundice—Capecitabine—colon cancer	0.00331	0.00331	CcSEcCtD
Piperacillin—Convulsion—Fluorouracil—colon cancer	0.00329	0.00329	CcSEcCtD
Piperacillin—Nervous system disorder—Vincristine—colon cancer	0.00326	0.00326	CcSEcCtD
Piperacillin—Thrombocytopenia—Vincristine—colon cancer	0.00325	0.00325	CcSEcCtD
Piperacillin—Anaphylactic shock—Irinotecan—colon cancer	0.00324	0.00324	CcSEcCtD
Piperacillin—Oedema—Irinotecan—colon cancer	0.00324	0.00324	CcSEcCtD
Piperacillin—Myalgia—Fluorouracil—colon cancer	0.00323	0.00323	CcSEcCtD
Piperacillin—Hyperhidrosis—Vincristine—colon cancer	0.00321	0.00321	CcSEcCtD
Piperacillin—Epistaxis—Capecitabine—colon cancer	0.0032	0.0032	CcSEcCtD
Piperacillin—Shock—Irinotecan—colon cancer	0.00318	0.00318	CcSEcCtD
Piperacillin—Nervous system disorder—Irinotecan—colon cancer	0.00317	0.00317	CcSEcCtD
Piperacillin—Agranulocytosis—Capecitabine—colon cancer	0.00317	0.00317	CcSEcCtD
Piperacillin—Thrombocytopenia—Irinotecan—colon cancer	0.00317	0.00317	CcSEcCtD
Piperacillin—Hyperhidrosis—Irinotecan—colon cancer	0.00313	0.00313	CcSEcCtD
Piperacillin—Hypotension—Vincristine—colon cancer	0.0031	0.0031	CcSEcCtD
Piperacillin—Oedema—Fluorouracil—colon cancer	0.0031	0.0031	CcSEcCtD
Piperacillin—Anaphylactic shock—Fluorouracil—colon cancer	0.0031	0.0031	CcSEcCtD
Piperacillin—Haemoglobin—Capecitabine—colon cancer	0.00306	0.00306	CcSEcCtD
Piperacillin—Haemorrhage—Capecitabine—colon cancer	0.00305	0.00305	CcSEcCtD
Piperacillin—Hepatitis—Capecitabine—colon cancer	0.00305	0.00305	CcSEcCtD
Piperacillin—Nervous system disorder—Fluorouracil—colon cancer	0.00304	0.00304	CcSEcCtD
Piperacillin—Thrombocytopenia—Fluorouracil—colon cancer	0.00303	0.00303	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00303	0.00303	CcSEcCtD
Piperacillin—Hypotension—Irinotecan—colon cancer	0.00302	0.00302	CcSEcCtD
Piperacillin—Urinary tract disorder—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Piperacillin—Insomnia—Vincristine—colon cancer	0.00301	0.00301	CcSEcCtD
Piperacillin—Urethral disorder—Capecitabine—colon cancer	0.00299	0.00299	CcSEcCtD
Piperacillin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00295	0.00295	CcSEcCtD
Piperacillin—Insomnia—Irinotecan—colon cancer	0.00293	0.00293	CcSEcCtD
Piperacillin—Hypotension—Fluorouracil—colon cancer	0.0029	0.0029	CcSEcCtD
Piperacillin—Erythema multiforme—Capecitabine—colon cancer	0.00288	0.00288	CcSEcCtD
Piperacillin—Fatigue—Vincristine—colon cancer	0.00286	0.00286	CcSEcCtD
Piperacillin—Dyspepsia—Irinotecan—colon cancer	0.00285	0.00285	CcSEcCtD
Piperacillin—Pain—Vincristine—colon cancer	0.00284	0.00284	CcSEcCtD
Piperacillin—Constipation—Vincristine—colon cancer	0.00284	0.00284	CcSEcCtD
Piperacillin—Flushing—Capecitabine—colon cancer	0.00283	0.00283	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00282	0.00282	CcSEcCtD
Piperacillin—Eosinophilia—Methotrexate—colon cancer	0.00281	0.00281	CcSEcCtD
Piperacillin—Insomnia—Fluorouracil—colon cancer	0.0028	0.0028	CcSEcCtD
Piperacillin—Fatigue—Irinotecan—colon cancer	0.00279	0.00279	CcSEcCtD
Piperacillin—Constipation—Irinotecan—colon cancer	0.00277	0.00277	CcSEcCtD
Piperacillin—Pain—Irinotecan—colon cancer	0.00277	0.00277	CcSEcCtD
Piperacillin—Angiopathy—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Piperacillin—Immune system disorder—Capecitabine—colon cancer	0.00275	0.00275	CcSEcCtD
Piperacillin—Chills—Capecitabine—colon cancer	0.00273	0.00273	CcSEcCtD
Piperacillin—Dyspepsia—Fluorouracil—colon cancer	0.00273	0.00273	CcSEcCtD
Piperacillin—Gastrointestinal pain—Vincristine—colon cancer	0.00272	0.00272	CcSEcCtD
Piperacillin—Pancytopenia—Methotrexate—colon cancer	0.00269	0.00269	CcSEcCtD
Piperacillin—Erythema—Capecitabine—colon cancer	0.00265	0.00265	CcSEcCtD
Piperacillin—Malnutrition—Capecitabine—colon cancer	0.00265	0.00265	CcSEcCtD
Piperacillin—Neutropenia—Methotrexate—colon cancer	0.00265	0.00265	CcSEcCtD
Piperacillin—Pain—Fluorouracil—colon cancer	0.00265	0.00265	CcSEcCtD
Piperacillin—Gastrointestinal pain—Irinotecan—colon cancer	0.00265	0.00265	CcSEcCtD
Piperacillin—Abdominal pain—Vincristine—colon cancer	0.00263	0.00263	CcSEcCtD
Piperacillin—Body temperature increased—Vincristine—colon cancer	0.00263	0.00263	CcSEcCtD
Piperacillin—Body temperature increased—Irinotecan—colon cancer	0.00256	0.00256	CcSEcCtD
Piperacillin—Abdominal pain—Irinotecan—colon cancer	0.00256	0.00256	CcSEcCtD
Piperacillin—Infestation—Methotrexate—colon cancer	0.00253	0.00253	CcSEcCtD
Piperacillin—Infestation NOS—Methotrexate—colon cancer	0.00253	0.00253	CcSEcCtD
Piperacillin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00251	0.00251	CcSEcCtD
Piperacillin—Renal failure—Methotrexate—colon cancer	0.00248	0.00248	CcSEcCtD
Piperacillin—Stomatitis—Methotrexate—colon cancer	0.00246	0.00246	CcSEcCtD
Piperacillin—Urticaria—Fluorouracil—colon cancer	0.00246	0.00246	CcSEcCtD
Piperacillin—Anaemia—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Piperacillin—Body temperature increased—Fluorouracil—colon cancer	0.00245	0.00245	CcSEcCtD
Piperacillin—Hypersensitivity—Vincristine—colon cancer	0.00245	0.00245	CcSEcCtD
Piperacillin—Epistaxis—Methotrexate—colon cancer	0.00238	0.00238	CcSEcCtD
Piperacillin—Hypersensitivity—Irinotecan—colon cancer	0.00238	0.00238	CcSEcCtD
Piperacillin—Asthenia—Vincristine—colon cancer	0.00238	0.00238	CcSEcCtD
Piperacillin—Leukopenia—Capecitabine—colon cancer	0.00238	0.00238	CcSEcCtD
Piperacillin—Agranulocytosis—Methotrexate—colon cancer	0.00236	0.00236	CcSEcCtD
Piperacillin—Asthenia—Irinotecan—colon cancer	0.00232	0.00232	CcSEcCtD
Piperacillin—Hypersensitivity—Fluorouracil—colon cancer	0.00228	0.00228	CcSEcCtD
Piperacillin—Haemoglobin—Methotrexate—colon cancer	0.00228	0.00228	CcSEcCtD
Piperacillin—Diarrhoea—Vincristine—colon cancer	0.00227	0.00227	CcSEcCtD
Piperacillin—Haemorrhage—Methotrexate—colon cancer	0.00227	0.00227	CcSEcCtD
Piperacillin—Hepatitis—Methotrexate—colon cancer	0.00227	0.00227	CcSEcCtD
Piperacillin—Myalgia—Capecitabine—colon cancer	0.00226	0.00226	CcSEcCtD
Piperacillin—Arthralgia—Capecitabine—colon cancer	0.00226	0.00226	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00224	0.00224	CcSEcCtD
Piperacillin—Urinary tract disorder—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Piperacillin—Urethral disorder—Methotrexate—colon cancer	0.00222	0.00222	CcSEcCtD
Piperacillin—Diarrhoea—Irinotecan—colon cancer	0.00221	0.00221	CcSEcCtD
Piperacillin—Dry mouth—Capecitabine—colon cancer	0.00221	0.00221	CcSEcCtD
Piperacillin—Dizziness—Vincristine—colon cancer	0.0022	0.0022	CcSEcCtD
Piperacillin—Pruritus—Fluorouracil—colon cancer	0.00219	0.00219	CcSEcCtD
Piperacillin—Oedema—Capecitabine—colon cancer	0.00217	0.00217	CcSEcCtD
Piperacillin—Erythema multiforme—Methotrexate—colon cancer	0.00215	0.00215	CcSEcCtD
Piperacillin—Dizziness—Irinotecan—colon cancer	0.00214	0.00214	CcSEcCtD
Piperacillin—Shock—Capecitabine—colon cancer	0.00213	0.00213	CcSEcCtD
Piperacillin—Nervous system disorder—Capecitabine—colon cancer	0.00212	0.00212	CcSEcCtD
Piperacillin—Diarrhoea—Fluorouracil—colon cancer	0.00212	0.00212	CcSEcCtD
Piperacillin—Thrombocytopenia—Capecitabine—colon cancer	0.00212	0.00212	CcSEcCtD
Piperacillin—Vomiting—Vincristine—colon cancer	0.00211	0.00211	CcSEcCtD
Piperacillin—Skin disorder—Capecitabine—colon cancer	0.0021	0.0021	CcSEcCtD
Piperacillin—Rash—Vincristine—colon cancer	0.00209	0.00209	CcSEcCtD
Piperacillin—Hyperhidrosis—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Piperacillin—Dermatitis—Vincristine—colon cancer	0.00209	0.00209	CcSEcCtD
Piperacillin—Headache—Vincristine—colon cancer	0.00208	0.00208	CcSEcCtD
Piperacillin—Angiopathy—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Piperacillin—Vomiting—Irinotecan—colon cancer	0.00206	0.00206	CcSEcCtD
Piperacillin—Immune system disorder—Methotrexate—colon cancer	0.00205	0.00205	CcSEcCtD
Piperacillin—Dizziness—Fluorouracil—colon cancer	0.00205	0.00205	CcSEcCtD
Piperacillin—Rash—Irinotecan—colon cancer	0.00204	0.00204	CcSEcCtD
Piperacillin—Dermatitis—Irinotecan—colon cancer	0.00204	0.00204	CcSEcCtD
Piperacillin—Chills—Methotrexate—colon cancer	0.00204	0.00204	CcSEcCtD
Piperacillin—Headache—Irinotecan—colon cancer	0.00203	0.00203	CcSEcCtD
Piperacillin—Hypotension—Capecitabine—colon cancer	0.00202	0.00202	CcSEcCtD
Piperacillin—Malnutrition—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Piperacillin—Erythema—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Piperacillin—Nausea—Vincristine—colon cancer	0.00197	0.00197	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00197	0.00197	CcSEcCtD
Piperacillin—Vomiting—Fluorouracil—colon cancer	0.00197	0.00197	CcSEcCtD
Piperacillin—Insomnia—Capecitabine—colon cancer	0.00196	0.00196	CcSEcCtD
Piperacillin—Rash—Fluorouracil—colon cancer	0.00195	0.00195	CcSEcCtD
Piperacillin—Dermatitis—Fluorouracil—colon cancer	0.00195	0.00195	CcSEcCtD
Piperacillin—Headache—Fluorouracil—colon cancer	0.00194	0.00194	CcSEcCtD
Piperacillin—Nausea—Irinotecan—colon cancer	0.00192	0.00192	CcSEcCtD
Piperacillin—Dyspepsia—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Piperacillin—Fatigue—Capecitabine—colon cancer	0.00187	0.00187	CcSEcCtD
Piperacillin—Pain—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Piperacillin—Constipation—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Piperacillin—Nausea—Fluorouracil—colon cancer	0.00184	0.00184	CcSEcCtD
Piperacillin—Anaemia—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Piperacillin—Gastrointestinal pain—Capecitabine—colon cancer	0.00177	0.00177	CcSEcCtD
Piperacillin—Leukopenia—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Piperacillin—Urticaria—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Piperacillin—Abdominal pain—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Piperacillin—Body temperature increased—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Piperacillin—Convulsion—Methotrexate—colon cancer	0.00171	0.00171	CcSEcCtD
Piperacillin—Myalgia—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
Piperacillin—Arthralgia—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
Piperacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Piperacillin—Anaphylactic shock—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Piperacillin—Hypersensitivity—Capecitabine—colon cancer	0.0016	0.0016	CcSEcCtD
Piperacillin—Nervous system disorder—Methotrexate—colon cancer	0.00158	0.00158	CcSEcCtD
Piperacillin—Thrombocytopenia—Methotrexate—colon cancer	0.00158	0.00158	CcSEcCtD
Piperacillin—Skin disorder—Methotrexate—colon cancer	0.00157	0.00157	CcSEcCtD
Piperacillin—Hyperhidrosis—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Piperacillin—Asthenia—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Piperacillin—Pruritus—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Piperacillin—Hypotension—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Piperacillin—Diarrhoea—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Piperacillin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00147	0.00147	CcSEcCtD
Piperacillin—Insomnia—Methotrexate—colon cancer	0.00146	0.00146	CcSEcCtD
Piperacillin—Dizziness—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Piperacillin—Dyspepsia—Methotrexate—colon cancer	0.00142	0.00142	CcSEcCtD
Piperacillin—Fatigue—Methotrexate—colon cancer	0.00139	0.00139	CcSEcCtD
Piperacillin—Pain—Methotrexate—colon cancer	0.00138	0.00138	CcSEcCtD
Piperacillin—Vomiting—Capecitabine—colon cancer	0.00138	0.00138	CcSEcCtD
Piperacillin—Rash—Capecitabine—colon cancer	0.00137	0.00137	CcSEcCtD
Piperacillin—Dermatitis—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Piperacillin—Headache—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Piperacillin—Gastrointestinal pain—Methotrexate—colon cancer	0.00132	0.00132	CcSEcCtD
Piperacillin—Nausea—Capecitabine—colon cancer	0.00129	0.00129	CcSEcCtD
Piperacillin—Urticaria—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Piperacillin—Abdominal pain—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Piperacillin—Body temperature increased—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Piperacillin—Hypersensitivity—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Piperacillin—Asthenia—Methotrexate—colon cancer	0.00116	0.00116	CcSEcCtD
Piperacillin—Pruritus—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Piperacillin—Diarrhoea—Methotrexate—colon cancer	0.0011	0.0011	CcSEcCtD
Piperacillin—Dizziness—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Piperacillin—Vomiting—Methotrexate—colon cancer	0.00102	0.00102	CcSEcCtD
Piperacillin—Rash—Methotrexate—colon cancer	0.00102	0.00102	CcSEcCtD
Piperacillin—Dermatitis—Methotrexate—colon cancer	0.00102	0.00102	CcSEcCtD
Piperacillin—Headache—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Piperacillin—Nausea—Methotrexate—colon cancer	0.000958	0.000958	CcSEcCtD
